United Therapeutics (UTHR) Other Non Operating Income (2009 - 2026)

United Therapeutics has reported Other Non Operating Income for 18 years, with the latest figure at -$46.3 million in Q1 2026.

• Quarterly Other Non Operating Income fell 976.74% year-over-year to -$46.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (up 2400.0% YoY) and the FY2025 annual result came in at $48.9 million, up 743.1% from the prior year.
• Other Non Operating Income eased to -$46.3 million in Q1 2026 per UTHR's latest filing, from $47.2 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $47.2 million in Q4 2025 and troughed at -$51.8 million in Q2 2022.
• A 5-year average of -$2.7 million and a median of -$600000.0 in 2023 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income tumbled 1818.52% in 2022, then surged 1915.38% in 2025.
• Over 5 years, Other Non Operating Income stood at -$5.3 million in 2022, then jumped by 88.68% to -$600000.0 in 2023, then plunged by 333.33% to -$2.6 million in 2024, then soared by 1915.38% to $47.2 million in 2025, then sank by 198.09% to -$46.3 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$46.3 million, $47.2 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.